Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting

Journal of Experimental Medicine

Volumn 186, Issue 9, 1997, Pages 1585-1590

  Körner, Heinrich ^a   Riminton, D Sean ^a   Strickland, Deborah H ^a   Lemckert, Frances A ^a   Pollard, John D ^b   Sedgwick, Jonathon D ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN PROTEIN; TUMOR NECROSIS FACTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DEMYELINATION; GENE TARGETING; LEUKOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; CELL MOVEMENT; CENTRAL NERVOUS SYSTEM; DEMYELINATING DISEASES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE DELETION; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; LEUKOCYTES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; MYELIN-ASSOCIATED GLYCOPROTEIN; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0038917435     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.186.9.1585     Document Type: Article

References (29)

1. Körner, H., and J.D. Sedgwick. 1996. Tumour necrosis factor and lymphotoxin: molecular aspects and role in tissuespecific autoimmunity. Immunol. Cell Biol. 74:465-472.
2. Raine, C.S. 1984. Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis. Lab. Invest. 50:608-635.
3. Baron, J.L., J.A. Madri, N.H. Ruddle, G. Hashim, and C.A. Janeway. Jr. 1993. Surface expression of α4 integrin by CD4 T cell is required for their entry into brain parenchyma. J. Exp. Med. 177:57-68.
4. Olsson, T. 1995. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Rev. 144:245-268.
5. Ruddle, N.H., C.M. Bergman, K.M. McGrath, E.G., Lingenheld, M.L. Grunnet, S.J. Padula, and R.B. Clark. 1990. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172:1193-1200.
6. Selmaj, K., C.S. Raine, and A.H. Cross. 1991. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann. Neurol. 30:694-700.
7. Baker, D., D. Butler, B.J. Scallon, J.K. O'Neill, J.L. Turk, and M. Feldmann. 1994. Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins. Eur. J. Immunol. 24:2040-2048.
8. Körner, H., A.L. Goodsall, F.A. Lemckert, B.J. Scallon, J. Ghrayeb, A.L. Ford, and J.D. Sedgwick. 1995. Unimpaired autoreactive T-cell traffic within the central nervous system during tumor necrosis factor receptor-mediated inhibition of experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA. 92:11066-11070.
9. Philip, R., and L.B. Epstein. 1986. Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1. Nature (Lond.). 323:86-89.
10. Selmaj, K.W., and C.S. Raine. 1988. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23:339-346.
11. Bazzoni, F., and B. Beutler. 1996. The tumor necrosis factor ligand and receptor families. N. Engl. J. Med. 334:1717-1725.
12. Frei, K., H.P. Eugster, M. Bopst, C.S. Constantinescu, E. Lavi, and A. Fontana. 1997. Tumor necrosis factor α and lymphotoxin α are not required for induction of acute experimental autoimmune encephalomyelitis. J. Exp. Med. 185: 2177-2182.
13. De Togni, P., J. Goellner, N.H. Ruddle, P.R. Streeter, A. Fick, S. Mariathasan, S.C. Smith, R. Carlson, L.P. Shornick, J. Strauss-Schoenberger et al. 1994. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science (Wash. DC). 264:703-707.
14. Theofilopoulos, A.N. 1995. The basis of autoimmunity: part II. Genetic predisposition. Immunol. Today. 16:150-159.
15. Körner, H., M. Cook, D.S. Riminton, F.A. Lemckert, R.M. Hoek, B. Ledermann, F. Köntgen, B. Fazekas de St. Groth, and J.D. Sedgwick. 1997. Distinct roles for lymphotoxin-α and tumor necrosis factor in organogenesis and spatial organisation of lymphoid tissue. Eur. J. Immunol. In press.
16. Gardinier, M.V., P. Amiguet, C. Linington, and J.M. Matthieu. 1992. Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily. J. Neurosci. Res. 33:177-187.
17. + T cells compared. J. Immunol. 154:4309-4321.
18. Linington, C., M. Bradl, H. Lassmann, C. Brunner, and K. Vass. 1988. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am. J. Pathol. 130:443-454.
19. Hickey, W.F., and H. Kimura. 1988. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in two. Science (Wash. DC). 239:290-292.
20. Ford, A.L., E. Foulcher, F.A. Lemckert, and J.D. Sedgwick. 1996. Microglia induce CD4 T lymphocyte final effector function and death. J. Exp. Med. 184:1737-1746.
21. Butcher, E.C., and L.J. Picker. 1996. Lymphocyte homing and homeostasis. Science (Wash. DC). 272:60-66.
22. Pasparakis, M., L. Alexopoulou, V. Episkopou, and G. Kollias. 1996. Immune and inflammatory responses in TNF-α-deficient mice: a critical requirement for TNFα in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 184:1397-1411.
23. Forster, R., A.E. Mattis, E. Kremmer, E. Wolf, G. Brem, and M. Lipp. 1996. A putative chemokine receptor, blr1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell. 87:1037-1047.
24. Mori, L., S. Iselin, G. De Libero, and W. Lesslauer. 1996. Attenuation of collagen-induced arthritis in 55-kDa TNF receptor 1 (TNFR1)-IgG1-treated and TNFR1-deficient mice. J. Immunol. 157:3178-3182.
25. Eugster, H.-P., M. Muller, U. Karrer, B.D. Car, B. Schnyder, V.M. Eng, G. Woerly, M. Le Hir, F. di Padova, M. Auget et al. 1996. Multiple immune abnormalities in tumor necrosis factor and lymphotoxin α double-deficient mice. Int. Immunol. 8:23-36.
26. Yang, X.D., R. Tisch, S.M. Singer, Z.A. Cao, R.S. Liblau, R.D. Schreiber, and H.O. McDevitt. 1994. Effect of tumor necrosis factor α on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J. Exp. Med. 180:995-1004.
27. Körner, H., F.A. Lemckert, S. Etteldorf, B.J. Scallon, and J.D. Sedgwick. 1997. Tumor necrosis factor blockade in actively-induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T-cell infiltration to the central nervous system. Eur. J. Immunol. 27:1973-1981.
28. Dick, A.D., P.G. McMenamin, H. Körner, B.J. Scallon, J. Ghrayeb, J.V. Forrester, and J.D. Sedgwick. 1996. Inhibition of tumor necrosis factor-activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina. Eur. J. Immunol. 26:1018-1025.
29. Klinkert, W.E.F., K. Kojima, W. Lesslauer, W. Rinner, H. Lassmann, and H. Wekerle. 1997. TNF-α receptor fusion protein prevents experimental auto-immune encephalomyelitis and demyelination in Lewis rats: an overview. J. Neuroimmunol. 72:163-168.